Northwest Investment Counselors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $194K | Buy |
+314
| New | +$194K | 0.04% | 150 |
|
|
2024
Q2 | – | Sell |
-238
| Closed | -$138K | – | 465 |
|
|
2024
Q1 | $138K | Buy |
+238
| New | +$138K | 0.03% | 160 |
|
|
2023
Q4 | – | Sell |
-232
| Closed | -$118K | – | 501 |
|
|
2023
Q3 | $118K | Buy |
232
+21
| +10% | +$10.6K | 0.03% | 170 |
|
|
2023
Q2 | $110K | Hold |
211
| – | – | 0.03% | 174 |
|
|
2023
Q1 | $122K | Hold |
211
| – | – | 0.03% | 177 |
|
|
2022
Q4 | $116K | Hold |
211
| – | – | 0.03% | 180 |
|
|
2022
Q3 | $107K | Hold |
211
| – | – | 0.04% | 166 |
|
|
2022
Q2 | $115K | Hold |
211
| – | – | 0.04% | 162 |
|
|
2022
Q1 | $125K | Hold |
211
| – | – | 0.03% | 163 |
|
|
2021
Q4 | $141K | Buy |
+211
| New | +$141K | 0.03% | 159 |
|
|
2021
Q2 | – | Sell |
-211
| Closed | -$96K | – | 413 |
|
|
2021
Q1 | $96K | Buy |
+211
| New | +$96K | 0.03% | 175 |
|
|
2020
Q4 | – | Sell |
-211
| Closed | -$93K | – | 407 |
|
|
2020
Q3 | $93K | Buy |
+211
| New | +$93K | 0.03% | 158 |
|
|
2019
Q4 | – | Sell |
-110
| Closed | -$32K | – | 462 |
|
|
2019
Q3 | $32K | Buy |
+110
| New | +$32K | 0.01% | 256 |
|
|
2017
Q4 | – | Sell |
-44
| Closed | -$8K | – | 293 |
|
|
2017
Q3 | $8K | Hold |
44
| – | – | ﹤0.01% | 309 |
|
|
2017
Q2 | $8K | Buy |
+44
| New | +$8K | ﹤0.01% | 271 |
|